Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients

Previous in vitro and in vivo studies have demonstrated the potential of using cysteinyl leukotriene receptor antagonists (LTRAs) for chemoprevention, but this has not been investigated in any clinical setting. We therefore investigated the chemopreventive effect of LTRAs in a nationwide population-...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Ming-Ju, Wu, Ping-Hsun, Sheu, Chau-Chyun, Hsu, Ya-Ling, Chang, Wei-An, Hung, Jen-Yu, Yang, Chih-Jen, Yang, Yi-Hsin, Kuo, Po-Lin, Huang, Ming-Shyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823742/
https://www.ncbi.nlm.nih.gov/pubmed/27052782
http://dx.doi.org/10.1038/srep23979

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823742/
https://www.ncbi.nlm.nih.gov/pubmed/27052782
http://dx.doi.org/10.1038/srep23979

Ejemplares similares